ReviewFrontiers in oncology2025
Management of ovarian granulosa cell tumor in childhood: a case report and recommendations for a multidisciplinary approach.
Review in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Juvenile granulosa cell tumor (jGCT) is a rare subtype of pure sex-cord tumors, mostly affecting patients under 20 years of age. As this tumor originates from ovarian cells specialized in sex steroid secretion, jGCT can present with endocrine disorders, including precocious puberty in prepubertal girls or menstrual irregularities in postpubertal patients. In other cases, jGCT may manifest with symptoms related to pelvic mass effects or acute abdomen, prompting urgent gynecologic or surgical evaluation. Most patients are diagnosed with ovarian-confined disease, and for these patients, the survival rates exceed 90% following surgery alone. However, advanced and relapsed disease remains a significant concern. As the survival rates for cancer continue to improve, addressing survivorship care is essential. Long-term follow-up for patients diagnosed with jGCT in childhood requires a multidisciplinary approach. We hereby describe a clinical case of jGCT diagnosed in an infant girl for whom a comprehensive multidisciplinary care plan was arranged. Through a comprehensive review of the literature, we developed a clinically applicable flowchart for the multidisciplinary management of jGCT at diagnosis and during follow-up, emphasizing the need for patient-centered care that integrates the work of oncologists, endocrinologists, surgeons, gynecologists, and geneticists.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.